Oral Immunotherapy for Treatment of Food Allergy: 2023 Update
This is an interactive course that provides information about the different types of food immunotherapy, with a focus on oral immunotherapy (OIT). We will review the history of OIT and examine the current evidence supporting OIT's use. We also will discuss the FDA-approved peanut oral immunotherapy product and the importance of shared decision making with patients and families to identify which patients might benefit most from this therapy. This course also highlights the risks and limitations associated with OIT.
Target Audience
- Allergist/immunologists
- Fellows-in-Training
- Allied Health Professionals
Learning Objectives
Upon completion of this course, the learner will be able to:
- Apply your understanding of benefits and limitations of food allergy testing to determine which patients qualify for oral food challenge vs. oral immunotherapy (OIT)
- Demonstrate understanding of the currently understood immunologic mechanisms and protocols of OIT
- Identify the benefits and limitations associated with OIT and the importance of shared decision making
- Review the prescribing information and risk mitigation strategies for the first FDA-approved peanut OIT drug
The information disclosed by the presenters and planning committee members was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Content Authors
Justin C. Greiwe, MD
Bernstein Allergy Group, Cincinnati, OH
Relevant Relationships: None
Jonathan A. Hemler, MD FAAAAI
University of Virginia School of Medicine
Relevant Relationships: None
Content Reviewers
Samuel Gubernick, DO FAAAAI
Family Allergy, Asthma, and Immunology Associates
Relevant Relationships: None
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All relevant financial relationships were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the information in the Faculty and Accreditation tabs.
- Click Begin (from the Overview, Register, or Begin tabs).
- Complete the OIT module and the assessment. You must achieve a score of 70% or higher to claim credit.
- Complete the activity evaluation.
- Claim your credits.
- Print or save your certificate.
AAAAI Privacy Policy
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Questions
Activity-related questions should be directed to cme@aaaai.org.
Available Credit
- 0.50 AttendanceAttendance credit.
- 0.50 CMECME credit.
Price
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari. Internet Explorer is no longer supported.
Pop-ups must be enabled in order to access all course content. The interactive course will pop up in a new window.